Conjunctival Vessels in Diabetes Using Functional Slit Lamp Biomicroscopy.
Journal
Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
received:
28
05
2020
accepted:
12
10
2020
pubmed:
18
12
2020
medline:
15
12
2021
entrez:
17
12
2020
Statut:
ppublish
Résumé
This study used functional slit lamp biomicroscopy (FSLB) to quantify conjunctival microvessel parameters in individuals with and without diabetes and examined whether these metrics could be used as surrogate markers of diabetes-related complications. A cross-sectional study of 98 controls (C), 13 individuals with diabetes without complications (D-C), and 21 with diabetes and related complications (D+C), which included retinopathy, nephropathy, neuropathy, and cardiovascular-, peripheral vascular-, and cerebrovascular diseases, was performed. Bulbar conjunctival metrics (venule diameter, length, axial velocity [Va], cross-sectional velocity [Vs], flow [Q], and branching complexity) were measured using FSLB (digital camera mounted on traditional slit lamp). The mean age was 60 ± 11 years, and demographics were similar across the groups. Va and Vs significantly differed between groups. Va was 0.51 ± 0.17 mm/s, 0.62 ± 0.17 mm/s, and 0.45 ± 0.17 mm/s in the C, D-C, and D+C groups, respectively (P = 0.025). Similarly, Vs was 0.35 ± 01.12, 0.43 ± 0.13, and 0.32 ± 0.13 mm/s in the C, D-C, and D+C groups, respectively (P = 0.031). Black individuals had increased Va, Vs, and Q compared with White individuals (P < 0.05), but differences in velocities persisted after accounting for race. Among patients with diabetes, Va and Vs correlated with number of organ systems affected (Va: ρ = -0.42, P = 0.016; Vs: ρ = -0.41, P = 0.021). Va, Vs, and Q significantly (P ≤ 0.005) discriminated between diabetic patients with and without complications (area under the receiver operating curve for Va = 0.81, Vs = 0.79, Q = 0.81). Bulbar conjunctival blood flow metrics measured by FSLB differed between controls, diabetic patients without complications, and diabetic patients with complications. FSLB is a quick, easily accessible, and noninvasive alternative that might estimate the burden of vascular complications in diabetes.
Identifiants
pubmed: 33332897
doi: 10.1097/ICO.0000000000002623
pii: 00003226-202108000-00002
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
950-957Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors have no funding or conflicts of interest to disclose.
Références
Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention; 2017.
Rowley WR, Bezold C, Arikan Y, et al. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag. 2017;20:6–12.
American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013;36:1033–1046.
Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289:76–79.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–986.
Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998;316:823–828.
American Diabetes Association. 11. Microvascular complications and foot care: Standards of medical care in diabetes-2019. Diabetes Care. 2019;42(suppl 1):S124–S138.
Kan C, Silva N, Golden SH, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013;36:480–489.
Cheung AT, Ramanujam S, Greer DA, et al. Microvascular abnormalities in the bulbar conjunctiva of patients with type 2 diabetes mellitus. Endocr Pract. 2001;7:358–363.
Owen CG, Newsom RS, Rudnicka AR, et al. Vascular response of the bulbar conjunctiva to diabetes and elevated blood pressure. Ophthalmology. 2005;112:1801–1808.
Cheung AT, Tomic MM, Chen PC, et al. Correlation of microvascular abnormalities and endothelial dysfunction in type-1 diabetes mellitus (T1DM): a real-time intravital microscopy study. Clin Hemorheol Microcirc. 2009;42:285–295.
Landau J, Davis E. The small blood-vessels of the conjunctiva and nailbed in diabetes mellitus. Lancet. 1960;2:731–734.
Bech K, Hansen E, Lorentzen SE, et al. The V/A ratio of the smaller vessels of the bulbar conjunctiva in diabetes mellitus. Diabetes. 1960;9:441–446.
Ditzel J, Sagild U. Morphologic and hemodynamic changes in the smaller blood vessels in diabetes mellitus. II. The degenerative and hemodynamic changes in the bulbar conjunctiva of normotensive diabetic patients. N Engl J Med. 1954;250:587–594.
Iroshan KA, De Zoysa ADN, Warnapura CL, et al. Detection of diabetes by macrovascular tortuosity of superior bulbar conjunctiva. Conf Proc IEEE Eng Med Biol Soc. 2018;2018:1–4.
Owen CG, Newsom RS, Rudnicka AR, et al. Diabetes and the tortuosity of vessels of the bulbar conjunctiva. Ophthalmology. 2008;115:e27–e32.
Schuerch K, Frech H, Zinkernagel M. Conjunctival microangiopathy in diabetes mellitus assessed with optical coherence tomography angiography. Transl Vis Sci Technol. 2020;9:10.
To WJ, Telander DG, Lloyd ME, et al. Correlation of conjunctival microangiopathy with retinopathy in type-2 diabetes mellitus (T2DM) patients. Clin Hemorheol Microcirc. 2011;47:131–141.
Shu X, Wang J, Hu L. A review of functional slit lamp biomicroscopy. Eye Vis (Lond). 2019;6:15.
Jiang H, Zhong J, DeBuc DC, et al. Functional slit lamp biomicroscopy for imaging bulbar conjunctival microvasculature in contact lens wearers. Microvasc Res. 2014;92:62–71.
Xu Z, Jiang H, Tao A, et al. Measurement variability of the bulbar conjunctival microvasculature in healthy subjects using functional slit lamp biomicroscopy (FSLB). Microvasc Res. 2015;101:15–19.
Khansari MM, Wanek J, Felder AE, et al. Automated assessment of hemodynamics in the conjunctival microvasculature network. IEEE Trans Med Imaging. 2016;35:605–611.
Karanam VC, Tamariz L, Batawi H, et al. Functional slit lamp biomicroscopy metrics correlate with cardiovascular risk. Ocul Surf. 2019;17:64–69.
Chen W, Batawi HI, Alava JR, et al. Bulbar conjunctival microvascular responses in dry eye. Ocul Surf. 2017;15:193–201.
Wang L, Yuan J, Jiang H, et al. Vessel sampling and blood flow velocity distribution with vessel diameter for characterizing the human bulbar conjunctival microvasculature. Eye Contact Lens. 2016;42:135–140.
Deneux T, Takerkart S, Grinvald A, et al. A processing work-flow for measuring erythrocytes velocity in extended vascular networks from wide field high-resolution optical imaging data. Neuroimage. 2012;59:2569–2588.
Koutsiaris AG, Tachmitzi SV, Papavasileiou P, et al. Blood velocity pulse quantification in the human conjunctival pre-capillary arterioles. Microvasc Res. 2010;80:202–208.
Koutsiaris AG, Tachmitzi SV, Batis N, et al. Volume flow and wall shear stress quantification in the human conjunctival capillaries and post-capillary venules in vivo. Biorheology. 2007;44:375–386.
Jiang H, Debuc DC, Rundek T, et al. Automated segmentation and fractal analysis of high-resolution non-invasive capillary perfusion maps of the human retina. Microvasc Res. 2013;89:172–175.
Talu S, Vladutiu C, Lupascu CA. Characterization of human retinal vessel arborisation in normal and amblyopic eyes using multifractal analysis. Int J Ophthalmol. 2015;8:996–1002.
Khansari MM, Wanek J, Tan M, et al. Assessment of conjunctival microvascular hemodynamics in stages of diabetic microvasculopathy. Sci Rep. 2017;7:45916.
Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med. 2012;2012:918267.
Sena CM, Pereira AM, Seica R. Endothelial dysfunction—a major mediator of diabetic vascular disease. Biochim Biophys Acta. 2013;1832:2216–2231.
Creager MA, Luscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108:1527–1532.
Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation. 2004;109:2511–2517.
Taherzadeh Z, Brewster LM, van Montfrans GA, et al. Function and structure of resistance vessels in black and white people. J Clin Hypertens (Greenwich). 2010;12:431–438.
An Y, Kang Y, Lee J, et al. Blood flow characteristics of diabetic patients with complications detected by optical measurement. Biomed Eng Online. 2018;17:25.